1-3 of 3
Naohiro Sekiguchi, M.D., Ph.D.
Close
Sort by
Journal Articles

Subcutaneous Injection Of Bortezomib, Combined With Doxorubicin and Dexamethasone (sPAD) Is Effective and Safety Induction Therapy For Untreated Multiple Myeloma Patients

Naoki Takezako, MD, PhD, Naohiro Sekiguchi, M.D., Ph.D., Akihisa Nagata, MD, PhD, Tsuyoshi Hagino, MD, PhD, Satoshi Noto, M.D., Ph.D., Kazuhiko Natori, M.D., Ph.D., Akiyoshi Miwa, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 5391.
https://doi.org/10.1182/blood.V122.21.5391.5391
Published: 2013
Journal Articles

ST2 Utilizes Distinct Pathways to Suppress Inflammatory Cytokine Production and Modulate Rapid Differentiation of Human Monocytes Into CD83 + Dendritic Cells.

Naoki Takezako, MD, PhD, Naohiro Sekiguchi, M.D., Ph.D., Akihisa Nagata, Takeshi Hagino, Satoshi Noto, M.D., Ph.D., Akiyoshi Miwa, MD
Journal: Blood
Blood (2012) 120 (21): 2133.
https://doi.org/10.1182/blood.V120.21.2133.2133
Published: 2012
Journal Articles

Recombinant Human Thrombomodulin in the Treatment of Acute Myeloid Leukemia Patients Complicated by Disseminated Intravascular Coagulation: Retrospective Analysis of the Outcomes Between the Patients with Heparin and with Recombinant Human Thrombomodulin Therapy

Naoki Takezako, MD, PhD, Naohiro Sekiguchi, M.D., Ph.D., Akihisa Nagata, Satoshi Noto, M.D., Ph.D., Akiyoshi Miwa, M.D.
Journal: Blood
Blood (2011) 118 (21): 1247.
https://doi.org/10.1182/blood.V118.21.1247.1247
Published: 2011